"Designing Growth Strategies is in our DNA"
The chronic wound care market size was valued at USD 12.48 billion in 2022 and is projected to grow from USD 13.29 billion in 2023 to USD 21.00 billion by 2030, exhibiting a CAGR of 6.8% during 2023-2030. North America dominated the global market with a share of 37.5% in 2022.
According to various research reports and data published by Mission Regional Medical Center, it was estimated that around 6.7 million people in the world were suffering from chronic wounds. Also, according to an article published by Fairfax Media in August 2021, it was estimated that around 420,000 people in Australia are diagnosed with various types of wounds each year. Chronic wounds are difficult to heal and are recognized by symptoms such as loss of skin or tissue surrounding the wound or by the duration required for healing. Once a wound becomes chronic, intensive medical intervention and chronic wound care products are required to treat the wound. The Wound Healing Society (WHS) has classified these wounds into four main categories, i.e., diabetic ulcers, pressure ulcers, venous ulcers, and arterial ulcers.
Also, it is observed that these wounds exert a huge economic burden on patients and healthcare systems globally. For instance, according to a research study published by SAGE Publications in August 2021, it was estimated that around USD 4.94 billion were spent on venous leg ulcers and other associated diseases in the U.S. Also, according to Fairfax Media, it was estimated that the Australian government spends around USD 3.00 billion per year for chronic wound care.
Reduction in Number of Patient Visits for Chronic Wound Care during COVID-19 Pandemic Adversely Affected Market
The COVID-19 pandemic negatively impacted a few medical device segments due to reduction of non-essential procedures and healthcare services. This factor resulted in the exemption of wound care from the essential procedures list and has been considered an elective procedure in most countries. Also, healthcare settings such as hospitals and specialty clinics were temporarily shut down and wound clinics accepted only emergency cases. Thus, this resulted in a significant drop in the number of patient visits in healthcare settings for chronic wound care.
Moreover, demand for wound products was severely affected due to a disruptive supply chain in the COVID-19 pandemic and the requirement of professional assistance during its usage. Also, several prominent players operating in the market experienced a significant decline in the revenue from chronic wound care products during the pandemic due to decline in their sales.
However, the revocation of lockdowns, and COVID-19 restrictions in 2021 by the majority of the countries, coupled with an increasing number of patient visits in the hospitals and wound centers, fueled the demand and adoption of wound dressings and other devices. Furthermore, the companies also observed a significant growth in their revenue due to increased demand. Thus, these factors propelled the market growth by a higher than the anticipated growth rate in 2021.
Request a Free sample to learn more about this report.
Increasing Application of Active Therapies in Treatment of Chronic Wounds
Several market players and research organizations are constantly focusing on the active therapy segment due to the increasing application of bioactive therapies such as bioequivalent and skin graft in treating these wounds. For instance, in July 2021, a team of researchers from the Michigan State University started developing biopolymer dressing to heal the injuries associated with diabetic foot ulcers.
Thus, such introduction of advanced active therapies by market players is leading to increasing adoption of active therapies, which subsequently will aid the global chronic wound care market growth during the forecast period.
Growing Prevalence of Chronic Wounds to Surge the Demand for Treatment
The rising prevalence of diabetic ulcers, pressure ulcers, and others is expected to increase the demand for dressings, devices, and active therapies to treat these wounds. For instance, according to a research article published by National Center for Biotechnology Information in December 2021, it was reported annually an estimated 1.0 to 3.0 million people in the U.S. are suffering from pressure injuries of the skin and soft tissues. Also, according to data published by National Center for Biotechnology Information in 2021, it was reported that the incidence of diabetic foot ulcers in Japan was 2.9 per 1000 people each year.
Hence, the increasing prevalence of different types of chronic wounds globally is generating a high demand for treatment products and, subsequently, fueling the adoption of wound dressings, devices, and other products during the forecast period.
Technological Advancement in Treatment Options is Propelling Market Growth
In October 2021, Healthium Medtech Limited launched TRUSHIELD NXT, a surgical wound dressing with patented infection prevention technology combined with 3D hydrocellular substrate to improve wound healing. Additionally, investments in R&D and the launch of several novel wound healing products such as foam dressing and others by market players is expected to fuel the adoption of advanced wound care products for the urgent treatment of diabetic foot ulcers, and others.
High Cost of Treatment and Inadequate Reimbursement Policies in Emerging Countries to Restrict Adoption
Even with a large patient pool with chronic wounds, certain factors are restricting the adoption of chronic wound care products globally. One of them is the high cost of products such as advanced wound dressings, chronic wound care devices, bioactive products coupled with lack of reimbursement for these products in emerging countries.
For instance, according to a research article published by Elsevier B.V. in March 2021, it was estimated that the cost of individual patients ranges from USD 894.7 to USD 98,730.2 for hospital-acquired pressure ulcer treatment. Hence, the high cost of treatment of these hard-to-heal ulcers and inadequate reimbursement policies, especially in emerging countries, have been instrumental in the lower adoption of active products and devices in the global market.
To know how our report can help streamline your business, Speak to Analyst
Rising Prevalence of Diabetes and Diabetic Ulcers Led to the Segmental Dominance in 2022
The market is segmented into diabetic ulcers, pressure ulcers, venous leg ulcers, and others in terms of type. The largest chronic wound care market share was captured by the diabetic ulcers segment in 2022. The segment's dominance is attributable to the higher prevalence of diabetes globally and the increasing incidence of diabetic ulcers among diabetic patients.
The pressure ulcers segment is expected to grow at a significant CAGR during the forecast period due to the increasing patient pool suffering from pressure ulcers and increasing expenditure on its treatment.
However, the venous leg ulcers segment is anticipated to register a moderate CAGR from 2023-2030.
High Efficiency Coupled with Technological Advancement Responsible for Dominance of Advanced Wound Dressings in 2022
Based on product, the market is segmented into advanced wound dressings, wound care devices, active therapy, and others. Advanced wound dressings segment accounted for a dominant market share in 2022. The dominance is attributed to the lower cost of wound dressings coupled with its high efficiency in managing various types of wounds. The devices segment is expected to grow at a significant CAGR during the forecast period due to the constant focus of market players in introducing advanced devices in the market.
The active therapy segment is projected to grow at a higher CAGR during the forecast period owing to the increasing use of active therapies in the urgent and effective treatment of chronic wounds.
Increasing Patient Flow in Hospitals & Wound Clinics to have a Dominant Market Share during the Forecast Period
Based on end user, the market is segmented into hospitals & wound clinics and home care settings & others. The hospitals & wound clinics segment is anticipated to dominate the market during the forecast period. The dominance is due to an increasing patient flow in hospitals suffering from hard-to-heal chronic wounds.
On the other hand, the home care setting & others segment is anticipated to register a significant CAGR by the end of the forecast period due to patients' rising preference shift from hospital to home care settings for personalized care.
North America Chronic Wound Care Market Size, 2022 (USD billion)
To get more information on the regional analysis of this market, Request a Free sample
The market size in North America stood at USD 4.68 billion in 2022. The dominance of this region is attributable to the growing prevalence of chronic wounds, higher cost of treatment, and presence of adequate reimbursement policies in the U.S and Canada. For instance, according to an article published by Mary Ann Liebert, Inc., in October 2021, it was reported that the prevalence of venous leg ulcers was around 1.69% among the U.S. adult population in 2020. Also, it was stated that the annual economic burden for venous leg ulcers was approximately USD 14.90 billion in the U.S. Thus, the huge patient pool suffering from chronic wounds results in the growing demand and adoption of wound dressings, and is responsible for the market dominance of this region.
Whereas, the market in Europe is anticipated to register a significant CAGR during the forecast period due to the increase in a patient population with chronic wounds coupled with higher expenditure on the treatment of diabetic ulcers, pressure ulcers, venous ulcers, and others. For instance, according to the article by Manchester University NHS Foundation Trust in February 2020, the annual cost of venous leg ulcer treatment was estimated to be USD 2.57 billion in the U.K.
The Asia Pacific market is expected to grow at a higher CAGR due to the region's constant focus on market players. Comparatively lower diagnosis and treatment rates in emerging countries, especially in China, and India, have been pivotal for the lower share of the region in the global market. However, growing awareness among the patient population toward available treatment options, and increasing per capita healthcare spending, has led to the entry of global players in the region. For instance, in April 2021, Essity Aktiebolag (publ) acquired the distribution rights of Sorbact in Australia and New Zealand, intending to prevent and treat chronic wounds.
To know how our report can help streamline your business, Speak to Analyst
However, Latin America and the Middle East & Africa accounted for a comparatively lower share of the market due to lack of awareness about wound care, lower per capita income, and inadequate reimbursement policies in these regions. According to a research article published by Elsevier B.V. in 2022, it was reported that the treatment cost of a diabetic foot ulcer is approximately USD 10,450.0 per patient in Latin America. Thus, this huge expense is unaffordable for the majority of the countries in this region. This factor results in limiting the adoption of dressings, and devices, and subsequently restraining the market growth during the study period.
Emphasis on New Product Launches and Company Acquisition to Reinforce the Leading Market Position
The market structure is consolidated, with major players such as Smith & Nephew, ConvaTec, Inc., and 3M, occupying a dominant market share in 2022. Factors such as a strong product portfolio for chronic and acute wounds, along with a wide distribution network, are primarily responsible for the dominance of these players in the global market. For instance, in January 2023, Convatec Group launched ConvaFoam in the U.S. market. The product is a super absorber foam dressing intended to manage highly exuding wounds, including venous leg ulcers, pressure ulcers, and diabetic foot ulcers.
Along with that, a strong emphasis on strategic expansion of their product offerings through the acquisition of domestic players is anticipated to provide a strong foothold in the global market. For instance, in January 2021, Integra LifeSciences Corporation announced the acquisition of ACell, Inc., intending to provide more comprehensive complex wound management solutions to the patients. Other key players engaged in the market are Cardinal Health, Coloplast Corp, Integra LifeSciences Corporation, B. Braun Melsungen AG, and Tissue Regenix.
An Infographic Representation of Chronic Wound Care Market
To get information on various segments, share your queries with us
The report provides a detailed analysis of the market and focuses on key aspects such as leading companies, product types, and leading applications of the product. Besides this, the report offers insights into the global market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market in the recent years.
CAGR of 6.8% from 2023-2030
Value (USD billion)
By Type, Product, End User, and Region
By End User
Fortune Business Insights says that the global market size was USD 12.48 billion in 2022 and is projected to reach USD 21.00 billion by 2030.
In 2022, the North America market value stood at USD 4.68 billion.
Growing at a CAGR of 6.8%, the market will exhibit steady growth during the forecast period (2023-2030).
The diabetic ulcers segment is expected to be the leading segment by type in this market during the forecast period.
The increasing prevalence of chronic wounds and the introduction of advanced products by market players are major factors driving the market growth.
Smith & Nephew, 3M, and ConvaTec Inc. are major global market players.
North America dominated the market share in 2022.
The launch of advanced technologies by market players such as active therapies NPWT are expected to drive the adoption in the global market.
“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”- U.S.-based biotechnology company focussing on treatment of chronic pain.
“Kudos to your team. Thank you very much for your support and agility to answer our questions.”- Europe-based provider of solutions to automate data centre operations.
“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”- India-based manufacturer of industrial and specialty intermediates with a strong global presence.
“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”- One of the largest cosmetics company in the world.
“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”- U.S. based startup operating in the cultivated meat market.
“We received the below report on the U.S. market from you. We were very satisfied with the report.”- Global hearing aids manufacturer.
“I just finished my first pass-through of the report. Great work! Thank you!”- U.S. based solar racking solutions provider.
“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”- World’s leading advisory firm.
“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”- Germany based machine construction company.
“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”- Japanese manufacturing company of stationery products.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry